# Novo Nordisk A/S - G8, X9 M.FI – FDA Inspection, Apr 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/db3fab11-abbb-487e-b474-adf67f6e209f
Source feed: FDA_Inspections

> FDA inspection 1316850 of Novo Nordisk A/S - G8, X9 M.FI, April 17, 2026. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1316850
- Company Name: Novo Nordisk A/S - G8, X9 M.FI
- Inspection Date: 2026-04-17
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1297668 - 2022-06-16](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/a73b5e51-19ef-492f-93ba-175b269567c1)
- FDA Inspection 1210000 - 2021-05-12
- FDA Inspection 1057701 - 2018-06-01
- FDA Inspection 965339 - 2016-04-14
- FDA Inspection 874067 - 2014-03-14

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ruben-c-ayala/6b5dadad-56b8-4af0-a65f-4685f71f0c8d)

Company: https://www.keypedia.com/companies/novo-nordisk-as-g8-x9-mfi/389db4db-1347-40e5-88ef-284fdcfa1a1d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8